Introduction
The discovery of endothelium-derived relaxing factor and its subsequent identification as nitric oxide (NO) revealed a new regulatory mechanism for bronchomotor and vascular tone.
1-NO has been detected in exhaled air, with stable concentrations at rest and increased concentrations after challenges in sensitized animals with antigen or in asthmatic patients. This implies that NO is endogenous and it may be one of the recently described epitheliumderived relaxing factors. 1, 11 Recently, it has been demonstrated that NO synthase can be induced by endogenous platelet activating factor (PAF) . 12 This is a phospholipid mediator that causes bronchoconstriction, lung inflammation and hyperresponsiveness. PAF is released by inflammatory cells in obstructive, inflammatory and asthmatic disorders. 13 Therefore, it has been suggested that PAF might be a mediator of endothelininduced bronchoconstriction in the guinea-pig. 14 Endothelin-1 (ET-1) is a potent vasoconstrictor 15 and bronchoconstrictor peptide [16] [17] [18] produced by endothelial cells and degraded predominantly in the pulmonary vasculature. ET-1, like PAF, also has a pathophysiological role. Immunoreactive ET-1 has been recovered in bronchoalveolar lavage fluid of asthmatic patients and high plasmatic levels of this peptide have been found in adult respiratory distress syndrome (ARDS). 19 ET-1 activates the cyclooxygenase pathway 2 and induces release of endothelial-derived relaxing factor. Recently it has been-suggested that inhalation of NO might be used as a therapeutic strategy to reduce symptoms of obstructive and hypertensive pulmonary disorders. 21 
Results
In all experimental conditions inhaled NO did not modify systemic blood pressure or heart rate, but changed pulmonary vascular pressure and mechanical properties of respiratory system. Figure 1A shows that in control conditions NO inhalation caused a significant decrease in pulmonary vascular pressure. This decrease in MPAP was associated with a change in the AV/AP relationship of the respiratory system, as evidenced in Fig. lB Figure 2B shows the AV/AP relationship obtained in control conditions, after treatment with ET-1 and after NO inhalation. The modest displacement of this relationship caused by ET-1 administration was completely reversed by inhalation of nitric oxide.
The changes in respiratory system work are reported in Fig. 2C (Fig. 2D) (Fig. 3A) .
The slope and the linearity of the AV/AP curve observed in control conditions were greatly affected by PAF administration, as evidenced in Fig. 3B '5 An important new regulatory mechanism of the pulmonary and systemic circulation >8 is attributed to nitric oxide, also known as endothelium-derived relaxing factor. Recent observations demonstrate that when NO is inhaled, it acts as a selective local pulmonary vasodilator, without causing systemic vasodilatation. 6, 7, 28 Our results confirm these findings and also suggest that in the pig NO has selective pulmonary vasodilator activity not only on preconstricted vascular smooth muscle, but also on normal vascular tone. Using ET-1 and PAF, which cause two different degrees of contraction, we also demonstrated that the NO vasodilator activity is correlated with the degree of vasoconstriction, because its effect is greater after administration of PAF, which causes a stronger pulmonary hypertension. The NO-dependent pulmonary vasodilator activity improves respiratory function. In fact, in control conditions the vasodilator activity of inhaled NO improves the distensibility of the respiratory system, as evidenced by displacement of the kV/AP relationship, even if it did not affect respiratory resistance. The 'knee' observed in the AV/AP curve at lower volumes in anaesthetized, paralysed, mechanically ventilated pigs, similarly to that observed in cats, 29 reflects different stresses within the tissue elements. The persistence of this 'knee' when NO is inhaled in control conditions shows that stress inequalities are not affected by NO, which essentially acts on vascular smooth muscle.
The area enclosed between the AP vs. AV curve represents the inspiratory work of the respiratory system. 3 The displacement of the AV/AP curve to the left by NO is an index of decreased work done by the respiratory system. Therefore, the present results show that when 80 ppm NO is inhaled for 6 min, it improves pulmonary vascular and mechanical functions of the respiratory system. The vasodilatation associated with the improvement of lung distensibility and with the decrease in inspiratory work favours the redistribution of blood flow to better ventilated areas of the lungs, improving gas exchange. 31 
